Vivos Therapeutics (VVOS) Goodwill (2019 - 2026)

Vivos Therapeutics (VVOS) has 8 years of Goodwill data on file, last reported at $8.6 million in Q1 2026.

• Quarterly Goodwill rose 201.51% year-over-year to $8.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $8.6 million (up 201.51% YoY) and the FY2025 annual result came in at $8.6 million, up 206.14% from the prior year.
• Goodwill was little changed at $8.6 million in Q1 2026 per VVOS's latest filing, from $8.6 million in the prior quarter.
• Across five years, Goodwill topped out at $8.6 million in Q4 2025 and bottomed at $2.8 million in Q4 2022.
• The 5-year median for Goodwill is $2.8 million (2022), against an average of $4.2 million.
• The widest annual swing landed in 2022, when Goodwill slipped 1.51%; it then surged 206.14% in 2025.
• Tracing VVOS's Goodwill over 5 years: stood at $2.8 million in 2022, then changed by 0.0% to $2.8 million in 2023, then changed by 0.0% to $2.8 million in 2024, then surged by 206.14% to $8.6 million in 2025, then changed by 0.0% to $8.6 million in 2026.
• Per Business Quant, the three latest VVOS Goodwill figures stand at $8.6 million (Q1 2026), $8.6 million (Q4 2025), and $8.4 million (Q3 2025).

Peer Comparison